AstraZeneca Revenue 2010-2024 | AZN

AstraZeneca revenue for the twelve months ending June 30, 2024 was $49.133B, a 10.45% increase year-over-year.

  • AstraZeneca annual revenue for 2023 was $45.811B, a 3.29% increase from 2022.
  • AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021.
  • AstraZeneca annual revenue for 2021 was $37.417B, a 40.58% increase from 2020.

AstraZeneca Revenue 2010-2024 | AZN

  • AstraZeneca annual revenue for 2023 was $45.811B, a 3.29% increase from 2022.
  • AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021.
  • AstraZeneca annual revenue for 2021 was $37.417B, a 40.58% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$737B
Novo Nordisk (NVO)$472.8B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$355.5B
Merck (MRK)$255.1B
Novartis AG (NVS)$218.3B
Pfizer (PFE)$155B
Sanofi (SNY)$130.1B
Innoviva (INVA)$1.2B